Delivery Order SPE2DR25D7068-SPE2DR26F5BN7
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 7, 2025, for the supply of Lidocaine 5% Patch 30s, a topical anesthetic medication commonly used for localized pain relief. This competitively awarded, non-set-aside contract has a ceiling value of $1,222.11 with a firm fixed price structure and an ultimate completion date of July 8, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a $1,318.74 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Lidocaine 5% Patch 30s, a topical anesthetic medication commonly used for localized pain relief. This firm fixed price delivery order, with an ultimate completion date of August 13, 2025, represents a child contract under AmerisourceBergen's broader relationship with DLA and will be performed at the company's Conshohocken, Pennsylvania location. The contract was...
- The Defense Logistics Agency awarded a $6,013.44 delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Lidocaine 5% patches (30-count units). This non-set-aside, competitively awarded contract reflects firm fixed pricing and is scheduled for completion by November 14, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,490.48 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, a topical anesthetic medication used for localized pain relief. The contract, executed on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a firm fixed price delivery order with no set-aside designation, indicating competitive award through open procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $5,629.60 to AmerisourceBergen Drug Corp for the delivery of Lidocaine 5% Patch 30s, a topical anesthetic medication commonly used for localized pain relief. This firm fixed price contract, awarded on November 13, 2025, with an ultimate completion date of November 14, 2025, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award utilized no set-aside designation, indicating it was competitively...
- The Defense Logistics Agency awarded a $3,218.76 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of September 17, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $41,111.42 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30S, a topical anesthetic medication. Issued on August 27, 2025, with an ultimate completion date of August 28, 2025, this firm fixed-price delivery order was competitively awarded with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $11,152.70 to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, a topical anesthetic medication commonly used for localized pain relief. The contract was competitively awarded on November 5, 2025, with an ultimate completion date of November 6, 2025, and is structured as a firm fixed-price delivery order with no set-aside designation. Performance will occur at the awardee's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $20,535.06 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, a topical pain relief medication. The contract is a firm fixed price delivery order with an ultimate completion date of November 18, 2025, and was competitively awarded without any set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,968.60 to AmerisourceBergen Drug Corp for 30 units of Lidocaine 5% Patch, a topical anesthetic commonly used for localized pain relief. The contract, awarded on September 23, 2025, with an ultimate completion date of September 24, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award to the vendor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- SPE2DR25D7068Indefinite Delivery Contract
- SPE2DR25D7068-SPE2DR26F5BN7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,143.84 to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Lidocaine 5% Patch 30S, a topical anesthetic medication commonly used for localized pain relief. This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 18, 2025, with fulfillment through AmerisourceBergen's operations in Conshohocken, Pennsylvania. The award includes no set-aside designation, reflecting AmerisourceBergen's competitive standing in federal pharmaceutical procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor, AmerisourceBergen serves as a critical vendor for military and federal healthcare systems, supplying a broad range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's federal contract portfolio demonstrates consistent capability to deliver both small-value transactions and substantial orders, supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare system requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 11/17/25 |